表紙
市場調查報告書
商品編碼
1036195

動物用診斷的全球市場:各產品(設備、消耗品),技術(免疫診斷、臨床生物化學、PCR、血液檢驗、尿液檢查),動物(狗、貓、牛、豬、其他) -至2027年的預測

Global Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, & Others)-Global Forecast to 2027

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球動物用診斷市場,由於伴侶動物增加,及人獸共通感染疾病的擴大,動物健康保險的需求增加,動物健康的支出增加,動物來源的食品需求擴大,獸醫師增加等的,促進成長。可是,寵物照護相關的費用增加,熟練的獸醫師不足,診斷基礎設施的限制等,預計成為妨礙市場成長的要素。還有寵物飼主以動物為對象的COVID-19 PCR檢驗數增加,帶給這個市場很大的機會。

本報告提供全球動物用診斷市場調查,市場概要,各產品、技術、動物的市場規模與預測(以金額為準),各地區、國家詳細趨勢,市場成長的推動要素及阻礙因素,市場機會,課題,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19對感染管理市場的影響
  • 市場趨勢

第5章 全球動物用診斷市場:各產品

  • 簡介
  • 消耗品
    • 牛病毒性腹瀉(BVD)
    • 流感
    • 口蹄疫(FMD)
    • 絲蟲症
    • 其他
  • 系統
  • 軟體

第6章 全球動物用診斷市場:各技術

  • 簡介
  • 免疫診斷
    • ELISA檢驗
    • 其他
  • 分子診斷
    • PCR
    • 其他
  • 臨床生物化學
  • 尿液檢查
  • 血液檢驗
  • 其他

第7章 全球動物用診斷市場:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第8章 競爭情形

  • 簡介
  • 主要企業的市場佔有率分析(2020年)
  • 競爭模式
    • 產品銷售
    • 夥伴關係、合作、契約
    • 收購
    • 擴張
    • 其他的發展

第9章 企業簡介

  • Agrolabo Spa
  • Biomerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Indical Bioscience GmbH
  • Neogen Corporation
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

第10章 附錄

目錄
Product Code: MEDE2112

The global veterinary diagnostics market is expected to grow at a CAGR of ~x% from 2020 to reach ~x billion by 2027. The growth is primarily attributed to growing companion animal population, prevalence of zoonotic diseases, growing demand for animal health insurance, increasing expenditure on animal health, rising demand for animal derived foods and increasing number of veterinary practitioners. However, rising pet care expenses, lack of skilled veterinarians and limitation of diagnostic infrastructure are expected to hinder the growth of the market. Rising use of PCR testing for COVID-19 in animals by pet owners provide great opportunities for this market.

By Product: Consumable segment dominated the market in 2020

By product, veterinary diagnostic market is segmented consumables and instruments. Consumables segment accounted for largest market share of veterinary diagnostic market in 2020. The large share of this market segment can be attributed to grown demand of these products in veterinary hospitals, clinics & labs, adoption of point of care diagnostics by pet owners and rising awareness about zoonotic diseases.

By Animal type: Companion animals accounted for the largest market share in 2020

Companion animals segment accounted for the largest market share of the veterinary diagnostic market, by animal type in 2020. The dominant share of companion animal segment was captured by dogs. The large market share can be ascribed by increasing obesity, cancer, diabetes and other diseases and growing concern among pet owners. In livestock animal segment, pigs accounted for largest market share due to rising consumption of pork and diagnostic tests for them.

By Technology: Molecular Diagnostics segment leaded the market in the forecast period

Based on technology, molecular diagnostics segment accounted for largest share of veterinary diagnostics market in the forecast period. The large share of this market segment can be attributed to growing usage of molecular diagnosis for the detection of veterinary diseases and reliable, specific & fast diagnosis. COVID-19 has further propelled the application for the rapid detection of virus in companion animals.

By Region: North America expected to dominate the regional market

North America is expected to dominate the veterinary diagnostics market by region. The large share is primarily attributed to increasing population of companion & livestock animals, rising consumption of meat & dairy products, technological advancement, rising pet insurance and growing healthcare expenditure on animals. APAC is expected to register highest CAGR. The growth can be attributed to increasing disposable income, adoption of pet animals and high demand for animal protein.

Competitive Scenario

  • Thermo Fisher Scientific Inc. (US)
  • Zoetis Inc. (US)
  • IDEXX Laboratories Inc. (US)
  • NEOGEN Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMerieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMerieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Agrolabo S.p.A. (Italy)
  • INDICAL BIOSCIENCE GmbH (Germany)
  • Randox Laboratories Ltd. (Ireland)
  • IDvet (France)
  • Biopanda Reagents (UK)
  • Bionote Inc. (South Korea)
  • BioChek (Netherlands)
  • Fassisi GmbH (Germany)
  • Biogal Galed Labs (Israel)
  • Alvedia (France)
  • SKYER Inc. (South Korea)
  • Shenzhen Bioeasy Biotechnology Co. Ltd. (China)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Infection Control Market
  • 4.4. Market Trends

5. Global Veterinary Diagnostics Market, By Product, 2019-2027 (USD Million)

  • 5.1. Introduction
  • 5.2. Consumables
    • 5.2.1. Bovine Viral Diarrhoea (BVD)
    • 5.2.2. Influenza
    • 5.2.3. Foot and Mouth Disease (FMD)
    • 5.2.4. Heartworm Diseases
    • 5.2.5. Other Diseases
  • 5.3. Systems
  • 5.4. Software

6. Global Veterinary Diagnostics Market, By Technology, 2019-2027 (USD Million)

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
    • 6.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Tests
    • 6.2.2. Other Immunodiagnostic Tests
  • 6.3. Molecular Diagnostics
    • 6.3.1. Polymerase Chain Reaction (PCR)
    • 6.3.2. Other Molecular Diagnostic Tests
  • 6.4. Clinical Biochemistry
  • 6.5. Urinalysis
  • 6.6. Hematology
  • 6.7. Other Technologies

7. Global Veterinary Diagnostics Market, By Geography, 2019-2027 (USD Million)

  • 7.1. North America
    • 7.1.1. US
    • 7.1.2. Canada
  • 7.2. Europe
    • 7.2.1. Germany
    • 7.2.2. UK
    • 7.2.3. France
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Rest of Europe
  • 7.3. Asia-Pacific
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. Rest of Asia-Pacific
  • 7.4. Rest of the World
    • 7.4.1. Latin America
    • 7.4.2. Middle East & Africa

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. Market Share Analysis, By Key Players (2020)
  • 8.3. Competitive Scenario
    • 8.3.1. Product Launches
    • 8.3.2. Partnerships, Collaborations and Agreements
    • 8.3.3. Acquisitions
    • 8.3.4. Expansions
    • 8.3.5. Other Developments

9. Company Profiles

  • 9.1. Agrolabo Spa
  • 9.2. Biomerieux S.A.
  • 9.3. Bio-Rad Laboratories, Inc.
  • 9.4. GD Animal Health
  • 9.5. Heska Corporation
  • 9.6. IDEXX Laboratories, Inc.
  • 9.7. IDvet
  • 9.8. Indical Bioscience GmbH
  • 9.9. Neogen Corporation
  • 9.10. Thermo Fisher Scientific Inc.
  • 9.11. Zoetis Inc.

10. Appendix